Kozlowski T, Monroy R, Xu Y, Glaser R, Awwad M, Cooper D K, Sachs D H
Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston 02129, USA.
Transplantation. 1998 Jul 27;66(2):176-82. doi: 10.1097/00007890-199807270-00006.
Mixed lymphohematopoietic chimerism can provide an effective means of inducing longterm immunological tolerance and has been documented in a monkey allograft model. A conditioning regimen including nonmyeloablative or myeloablative irradiation and splenectomy has been used to induce chimerism in a pig-to-primate transplantation model. Since the presence of anti-Gal(alpha)1-3Gal (alphaGal) natural antibodies leads to the hyperacute rejection of pig organs transplanted into primates, extracorporeal immunoaffinity adsorption (EIA) of anti-alphaGal antibodies is also included in the regimen. The effect of the tolerance induction protocol on the anti-alphaGal antibody response has been assessed.
Anti-alphaGal antibody was measured after the EIA of plasma through an alphaGal immunoaffinity column in baseline studies involving two unmodified baboons, one splenectomized baboon, and one baboon that received a challenge with porcine bone marrow (BM), and in three groups of baboons (n=2 in each group) that received different conditioning regimens for tolerance induction. Group 1 received a nonmyeloablative conditioning regimen without porcine BM transplantation. Group 2 received nonmyeloablative conditioning with pig BM transplantation and pig cytokine therapy. Group 3 received myeloablative conditioning, an autologous BM transplant (with BM depleted of CD2+ or CD2+/CD20+ cells), and pig BM transplantation.
In the baseline studies, a single EIA of anti-alphaGal antibodies in an unmodified animal initially depleted anti-alphaGal antibody, followed by a mild rebound. Nonmyeloablative conditioning (group 1) in the absence of pig cell exposure reduced the rate of anti-alphaGal antibody return. Pig BM cells markedly stimulated anti-alphaGal antibody production in an unmodified baboon (alphaGal IgM and IgG levels increased 40- and 220-fold, respectively). This response was significantly reduced (to an only 2- to 5.5-fold increase of IgM and IgG) in baboons undergoing nonmyeloablative conditioning (group 2). A myeloablative conditioning regimen (group 3) prevented the antibody response to pig BM, with the reduction in response being greater in the baboon that received autologous BM depleted of both CD2+ and CD20+ cells. No new antibody directed against pig non-aGal antigens was detected in any baboon during the 1 month follow-up period.
(i) EIA of anti-alphaGal antibody in unmodified baboons results in a transient depletion followed by a mild rebound of antibody; (ii) exposure to pig BM cells results in a substantial increase in anti-alphaGal antibody production; (iii) a nonmyeloablative conditioning regimen reduces the rate of antibody return and (iv) markedly reduces the response to pig BM cells; (v) the anti-alphaGal response is completely suppressed by a myeloablative regimen if CD2+ and CD20+ cells are eliminated from the autologous BM inoculum. Furthermore, (vi) challenge with pig BM cells appears to stimulate only an anti-alphaGal antibody response without the development of other (non-alphaGal) anti-pig antibodies. We conclude that regimens used for T-cell tolerance induction can be beneficial in reducing the anti-alphaGal antibody response to porcine BM.
混合淋巴细胞造血嵌合体可提供一种诱导长期免疫耐受的有效方法,并且已在猴同种异体移植模型中得到证实。在猪到灵长类动物的移植模型中,一种包括非清髓性或清髓性照射及脾切除术的预处理方案已被用于诱导嵌合体。由于抗Gal(α)1-3Gal(αGal)天然抗体的存在会导致移植到灵长类动物体内的猪器官发生超急性排斥反应,因此该预处理方案中还包括抗αGal抗体的体外免疫亲和吸附(EIA)。已评估了耐受诱导方案对抗αGal抗体反应的影响。
在基线研究中,通过αGal免疫亲和柱对血浆进行EIA后,测量抗αGal抗体,这些研究涉及两只未处理的狒狒、一只脾切除的狒狒和一只接受猪骨髓(BM)攻击的狒狒,以及三组接受不同耐受诱导预处理方案的狒狒(每组n = 2)。第1组接受无猪BM移植的非清髓性预处理方案。第2组接受猪BM移植和猪细胞因子治疗的非清髓性预处理。第3组接受清髓性预处理、自体BM移植(BM中CD2+或CD2+/CD20+细胞已清除)和猪BM移植。
在基线研究中,未处理动物单次进行抗αGal抗体的EIA最初会使抗αGal抗体减少,随后出现轻度反弹。在无猪细胞暴露的情况下进行非清髓性预处理(第1组)降低了抗αGal抗体恢复的速率。猪BM细胞在未处理的狒狒中显著刺激抗αGal抗体产生(αGal IgM和IgG水平分别增加40倍和220倍)。在接受非清髓性预处理的狒狒(第2组)中,这种反应显著降低(IgM和IgG仅增加2至5.5倍)。清髓性预处理方案(第3组)可防止对猪BM的抗体反应,在接受CD2+和CD20+细胞均已清除的自体BM的狒狒中,反应降低更为明显。在1个月的随访期内,未在任何狒狒中检测到针对猪非αGal抗原的新抗体。
(i)未处理的狒狒中抗αGal抗体的EIA导致抗体短暂减少,随后出现轻度反弹;(ii)暴露于猪BM细胞会导致抗αGal抗体产生大幅增加;(iii)非清髓性预处理方案降低了抗体恢复速率,(iv)并显著降低了对猪BM细胞的反应;(v)如果从自体BM接种物中清除CD2+和CD20+细胞,清髓性方案可完全抑制抗αGal反应。此外,(vi)用猪BM细胞攻击似乎仅刺激抗αGal抗体反应,而不会产生其他(非αGal)抗猪抗体。我们得出结论,用于诱导T细胞耐受的方案在降低对猪BM的抗αGal抗体反应方面可能是有益的。